xml: <clinical_study>
    <!-- This xml conforms to an XML Schema at:
      https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
    <required_header>
      <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
      <link_text>Link to the current ClinicalTrials.gov record.</link_text>
      <url>https://clinicaltrials.gov/ct2/show/NCT05971615</url>
    </required_header>
    <id_info>
      <org_study_id>17-076</org_study_id>
      <nct_id>NCT05971615</nct_id>
    </id_info>
    <brief_title>Evaluate the Relevance of the Use of Peripheral Venous Blood Gases for the Care of Patients in the S.A.U.V (Vital Emergency Rooms) of the CHU de Caen</brief_title>
    <acronym>GDS</acronym>
    <official_title>Evaluate the Relevance of the Use of Peripheral Venous Blood Gases for the Care of Patients in the S.A.U.V (Vital Emergency Rooms) of the CHU de Caen</official_title>
    <sponsors>
      <lead_sponsor>
        <agency>University Hospital, Caen</agency>
        <agency_class>Other</agency_class>
      </lead_sponsor>
    </sponsors>
    <source>University Hospital, Caen</source>
    <oversight_info>
      <has_dmc>No</has_dmc>
      <is_fda_regulated_drug>No</is_fda_regulated_drug>
      <is_fda_regulated_device>No</is_fda_regulated_device>
    </oversight_info>
    <brief_summary>
      <textblock>
        concordance between the lactate values on peripheral venous and arterial blood gases in all&#xD;
        patients receiving an arterial sample on their arrival in the S.A.U.V.&#xD;
      </textblock>
    </brief_summary>
    <overall_status>Completed</overall_status>
    <start_date type="Actual">January 15, 2020</start_date>
    <completion_date type="Actual">December 18, 2020</completion_date>
    <primary_completion_date type="Actual">December 18, 2020</primary_completion_date>
    <phase>N/A</phase>
    <study_type>Interventional</study_type>
    <has_expanded_access>No</has_expanded_access>
    <study_design_info>
      <allocation>N/A</allocation>
      <intervention_model>Single Group Assignment</intervention_model>
      <primary_purpose>Other</primary_purpose>
      <masking>None (Open Label)</masking>
    </study_design_info>
    <primary_outcome>
      <measure>lactates on peripheral venous and arterial blood gases</measure>
      <time_frame>baseline</time_frame>
      <description>mmol/L</description>
    </primary_outcome>
    <number_of_arms>1</number_of_arms>
    <enrollment type="Actual">90</enrollment>
    <condition>Critical Illness</condition>
    <arm_group>
      <arm_group_label>Peripheral Venous Blood Gases</arm_group_label>
      <arm_group_type>Other</arm_group_type>
    </arm_group>
    <intervention>
      <intervention_type>Other</intervention_type>
      <intervention_name>peripheral venous blood gases</intervention_name>
      <description>peripheral venous blood gases</description>
      <arm_group_label>Peripheral Venous Blood Gases</arm_group_label>
    </intervention>
    <eligibility>
      <criteria>
        <textblock>
          Inclusion Criteria:&#xD;
  &#xD;
            -  one of this condition in emergency unit :&#xD;
  &#xD;
                 1. acute respiratory distress&#xD;
  &#xD;
                 2. a suspicion of an acid-base disorder&#xD;
  &#xD;
                 3. a state of shock&#xD;
  &#xD;
                 4. Pathologies requiring monitoring of the respiratory system&#xD;
  &#xD;
                 5. Patient under NIV&#xD;
  &#xD;
                 6. Poisoning&#xD;
  &#xD;
                 7. Coma with a Glasgow score &lt; or equal to 8&#xD;
  &#xD;
          Exclusion Criteria:&#xD;
  &#xD;
            -  Patient presenting another pathology supported in SAUV not requiring the realization&#xD;
               of arterial blood gases&#xD;
  &#xD;
            -  Patient aged &lt; 18 years&#xD;
  &#xD;
            -  Pregnant or breastfeeding woman&#xD;
        </textblock>
      </criteria>
      <gender>All</gender>
      <minimum_age>18 Years</minimum_age>
      <maximum_age>70 Years</maximum_age>
      <healthy_volunteers>No</healthy_volunteers>
    </eligibility>
    <location>
      <facility>
        <name>CAEN University Hospital</name>
        <address>
          <city>Caen</city>
          <country>France</country>
        </address>
      </facility>
    </location>
    <location_countries>
      <country>France</country>
    </location_countries>
    <verification_date>July 2023</verification_date>
    <study_first_submitted>May 23, 2023</study_first_submitted>
    <study_first_submitted_qc>July 25, 2023</study_first_submitted_qc>
    <study_first_posted type="Actual">August 2, 2023</study_first_posted>
    <last_update_submitted>July 25, 2023</last_update_submitted>
    <last_update_submitted_qc>July 25, 2023</last_update_submitted_qc>
    <last_update_posted type="Actual">August 2, 2023</last_update_posted>
    <responsible_party>
      <responsible_party_type>Sponsor</responsible_party_type>
    </responsible_party>
    <condition_browse>
      <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
      <mesh_term>Emergencies</mesh_term>
      <mesh_term>Critical Illness</mesh_term>
    </condition_browse>
    <patient_data>
      <sharing_ipd>No</sharing_ipd>
    </patient_data>
    <!-- Results have not yet been posted for this study                                          -->
  </clinical_study>
  
  
text: download date: ClinicalTrials.gov processed this data on September 20, 2023
  link text: Link to the current ClinicalTrials.gov record.
  url: https://clinicaltrials.gov/ct2/show/NCT05971615
  org study id: 17-076
  nct id: NCT05971615
  lead sponsor: 
  has dmc: No
  is fda regulated drug: No
  is fda regulated device: No
  concordance between the lactate values on peripheral venous and arterial blood gases in all
        patients receiving an arterial sample on their arrival in the S.A.U.V.
  allocation: N/A
  intervention model: Single Group Assignment
  primary purpose: Other
  masking: None (Open Label)
  measure: lactates on peripheral venous and arterial blood gases
  time frame: baseline
  description: mmol/L
  arm group label: Peripheral Venous Blood Gases
  arm group type: Other
  intervention type: Other
  intervention name: peripheral venous blood gases
  description: peripheral venous blood gases
  arm group label: Peripheral Venous Blood Gases
  criteria: 
  gender: All
  minimum age: 18 Years
  maximum age: 70 Years
  healthy volunteers: No
  facility: 
  country: France
  responsible party type: Sponsor
  mesh term: Emergencies
  mesh term: Critical Illness
  sharing ipd: No